GL1X · GenesisL1 explorer

MolNFT v1 · #113098 · protein

The structure of GH101 from streptococcus pneumoniae TIGR4 in complex with pugt

5A57 · Endo-alpha-N-acetylgalactosaminidase: “The structure of GH101 from streptococcus pneumoniae TIGR4 in complex with pugt”. X-ray diffraction, 3 ligands (5G0, GAL, CA), 12 pockets (best druggability 0.80). MolNFT v1 #113098 on…

PDB
5A57
Type
protein
Length
1,107 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Endo-alpha-N-acetylgalactosaminidase
UniProt
Q2MGH6
Ligands
5G0, GAL, CA
Pockets
12 · best druggability 0.80

Structure

x-ray diffraction · 1 distinct chain · 15% helix, 37% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AEndo-alpha-N-acetylgalactosaminidaseprotein110715% helix, 37% strandQ2MGH6

Ligands and binding sites

  • 5G0 · (Z)-[(3R,4R,5R,6R)-3-acetamido-6-(hydroxymethyl)-4,5-bis(oxidanyl)oxan-2-ylidene]amino] N-phenylcarbamate · ligand · chains A
  • GAL · beta-D-galactopyranose · sugar · chains A
  • CA · Calcium ion · metal · 3 copies · chains A
  • EDO · 1,2-ethanediol · additive · 23 copies · chains A
  • CIT · Citric acid · additive · 2 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

12 pockets found on a 1 Å grid, 7 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12070.800.9434EDO
2710.740.9822empty
3940.600.8823empty
42160.600.8024empty
52630.560.7739empty

Compared structures

  • 5A57 · The structure of GH101 from Streptococcus pneumoniae TIGR4 in complex with PUGT · the same entry in another collection · chain A against A, TM-score 1.00
  • Q2MGH6 · AlphaFold monomer V2.0 prediction for endo-alpha-N- acetylgalactosaminidase (Q2MGH6) · a predicted model of the same protein · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.